Evolus Reports Third Quarter 2022 Results and Provides Business Update
Reported Sales Up 27% to $33.9 Million; Success of ‘Switch Your Tox’ Promotion Contributes to $3.5 Million Incremental Increase in Deferred Revenue Over Q2 and Understates Strength of Results‘Switch Your Tox’ Drives Record Consumer Rewards Redemptions and New Purchasing AccountsReiterates Full-Year 2022 Net Revenue...
Source: pharmiweb.com